120 related articles for article (PubMed ID: 17616744)
21. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
22. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice.
Dorn GW; Robbins J; Ball N; Walsh RA
Am J Physiol; 1994 Jul; 267(1 Pt 2):H400-5. PubMed ID: 8048605
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice.
Marano G; Palazzesi S; Vergari A; Catalano L; Gaudi S; Testa C; Canese R; Carpinelli G; Podo F; Ferrari AU
Pflugers Arch; 2003 Jul; 446(4):429-36. PubMed ID: 12715181
[TBL] [Abstract][Full Text] [Related]
24. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
25. Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice.
Maslov MY; Chacko VP; Stuber M; Moens AL; Kass DA; Champion HC; Weiss RG
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H387-91. PubMed ID: 16963614
[TBL] [Abstract][Full Text] [Related]
26. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.
Buys ES; Raher MJ; Blake SL; Neilan TG; Graveline AR; Passeri JJ; Llano M; Perez-Sanz TM; Ichinose F; Janssens S; Zapol WM; Picard MH; Bloch KD; Scherrer-Crosbie M
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H620-7. PubMed ID: 17416602
[TBL] [Abstract][Full Text] [Related]
27. Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats.
Gardner JD; Brower GL; Janicki JS
J Appl Physiol (1985); 2005 Oct; 99(4):1378-83. PubMed ID: 15961607
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
[TBL] [Abstract][Full Text] [Related]
29. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.
Norton GR; Woodiwiss AJ; Gaasch WH; Mela T; Chung ES; Aurigemma GP; Meyer TE
J Am Coll Cardiol; 2002 Feb; 39(4):664-71. PubMed ID: 11849866
[TBL] [Abstract][Full Text] [Related]
30. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
[TBL] [Abstract][Full Text] [Related]
31. Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.
Weinheimer CJ; Kovacs A; Evans S; Matkovich SJ; Barger PM; Mann DL
Circ Heart Fail; 2018 May; 11(5):e004351. PubMed ID: 29716898
[TBL] [Abstract][Full Text] [Related]
32. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
33. Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1.
Mito S; Ozono R; Oshima T; Yano Y; Watari Y; Yamamoto Y; Brydun A; Igarashi K; Yoshizumi M
Hypertension; 2008 Jun; 51(6):1570-7. PubMed ID: 18426999
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
Giani JF; Muñoz MC; Mayer MA; Veiras LC; Arranz C; Taira CA; Turyn D; Toblli JE; Dominici FP
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1003-13. PubMed ID: 20061544
[TBL] [Abstract][Full Text] [Related]
35. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
36. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
37. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
38. ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin.
O'Shea KM; Chess DJ; Khairallah RJ; Hecker PA; Lei B; Walsh K; Des Rosiers C; Stanley WC
Lipids Health Dis; 2010 Sep; 9():95. PubMed ID: 20819225
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in molecular remodeling in pressure overload hypertrophy.
Weinberg EO; Thienelt CD; Katz SE; Bartunek J; Tajima M; Rohrbach S; Douglas PS; Lorell BH
J Am Coll Cardiol; 1999 Jul; 34(1):264-73. PubMed ID: 10400020
[TBL] [Abstract][Full Text] [Related]
40. Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure.
Nakamura M; Odanovic N; Nakada Y; Dohi S; Zhai P; Ivessa A; Yang Z; Abdellatif M; Sadoshima J
Cardiovasc Res; 2021 Sep; 117(11):2365-2376. PubMed ID: 33070172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
